Mukesh Yadav
University of Maryland, Baltimore
ORCID: 0000-0002-3661-5141Also affiliated with Maharishi Markandeshwar University, Mullana
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer”.
Prabhat Singh Malik, Sachin Khurana, Deepali Jain, Sreenivas Vishnubhatla, Mukesh Yadav +4 more
Yeap Ng, Bih-Rong Wei, Thomas D. Madsen, Mukesh Yadav, R. Mark Simpson +3 more
Anjelika Gasilina, Mukesh Yadav, Paul A. Randazzo, Pei-Wen Chen
Xiaoying Jian, Olivier Soubias, Hye‐Young Yoon, Mukesh Yadav, Sarah Hammoudeh +9 more
Mukesh Yadav, William Ghann, Jamal Uddin, Bahman Anvari, Vikas Kundra +1 more